These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24063853)

  • 1. Evidence-based medicine and the role of the private sector in assisted reproduction: a response to Dr Fishel's commentary 'Evidenced-based medicine and the role of the National Health Service in assisted reproduction'.
    Braude P; Khalaf Y
    Reprod Biomed Online; 2013 Nov; 27(5):570-2. PubMed ID: 24063853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based medicine and the role of the National Health Service in assisted reproduction.
    Fishel S
    Reprod Biomed Online; 2013 Nov; 27(5):568-9. PubMed ID: 24060186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy outcomes after assisted human reproduction.
    Okun N; Sierra S; ;
    J Obstet Gynaecol Can; 2014 Jan; 36(1):64-83. PubMed ID: 24444289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who should pay for assisted reproductive techniques? Answers from patients, professionals and the general public in Germany.
    Rauprich O; Berns E; Vollmann J
    Hum Reprod; 2010 May; 25(5):1225-33. PubMed ID: 20228390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UK's policy on genetic testing services supplied direct to the public -- two spheres and two tiers.
    Holtzman NA
    Community Genet; 1998; 1(1):49-52. PubMed ID: 11660582
    [No Abstract]   [Full Text] [Related]  

  • 6. The educational and professional status of clinical embryology and clinical embryologists in Europe.
    Kovačič B; Plas C; Woodward BJ; Verheyen G; Prados FJ; Hreinsson J; De los Santos MJ; Magli MC; Lundin K; Plancha CE
    Hum Reprod; 2015 Aug; 30(8):1755-62. PubMed ID: 26071417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
    Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
    Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2006.
    Mansour R; Ishihara O; Adamson GD; Dyer S; de Mouzon J; Nygren KG; Sullivan E; Zegers-Hochschild F
    Hum Reprod; 2014 Jul; 29(7):1536-51. PubMed ID: 24795090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. School-based clinics combat teen pregnancy.
    Contracept Technol Update; 1985 Apr; 6(4):53-7. PubMed ID: 12313867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2008, 2009 and 2010.
    Dyer S; Chambers GM; de Mouzon J; Nygren KG; Zegers-Hochschild F; Mansour R; Ishihara O; Banker M; Adamson GD
    Hum Reprod; 2016 Jul; 31(7):1588-609. PubMed ID: 27207175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometriosis and assisted reproduction: the role for reproductive surgery?
    De Hondt A; Meuleman C; Tomassetti C; Peeraer K; D'Hooghe TM
    Curr Opin Obstet Gynecol; 2006 Aug; 18(4):374-9. PubMed ID: 16794415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morals or markets? Regulating assisted reproductive technologies as morality or economic policies in the states.
    Heidt-Forsythe E
    AJOB Empir Bioeth; 2017; 8(1):58-67. PubMed ID: 28949871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixing private and public treatment in the UK's National Health Service: a challenge to core constitutional principles?
    Syrett K
    Eur J Health Law; 2010 Jun; 17(3):235-55. PubMed ID: 20666286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The wobbly evidence base of reproductive medicine.
    Evers JL
    Reprod Biomed Online; 2013 Dec; 27(6):742-6. PubMed ID: 24095628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oocyte vitrification and its impact on the clinical practice of assisted reproduction].
    Boyer P; Tourame P; Gervoise-Boyer M
    Gynecol Obstet Fertil; 2012 Nov; 40(11):687-90. PubMed ID: 23099025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What counts and how to count it: physicians' constructions of evidence in a disinvestment context.
    Hodgetts K; Elshaug AG; Hiller JE
    Soc Sci Med; 2012 Dec; 75(12):2191-9. PubMed ID: 22963922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The appeal to nature implicit in certain restrictions on public funding for assisted reproductive technology.
    Carter D; Braunack-Mayer A
    Bioethics; 2011 Oct; 25(8):463-71. PubMed ID: 21929706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assisted reproductive technology use and outcomes among women with a history of cancer.
    Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
    Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What would an environmentally sustainable reproductive technology industry look like?
    Richie C
    J Med Ethics; 2015 May; 41(5):383-7. PubMed ID: 25060852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.